Catalytic asymmetric hydrogenation (CAH) is a preeminent example of asymmetric transition metal catalysis and among the most widely used chemical transformations for introducing chirality in the pharmaceutical industry.^[@ref1]^ Given its utility, many chiral catalyst/substrate combinations have been developed to address different structural challenges in asymmetric synthesis;^[@ref2]^ however, relatively few are effective for the CAH of tetrasubstituted alkenes. Furthermore, such catalysts are often limited to substrates wherein the π-system is activated by aromatic substitution^[@ref3]^ or α,β-conjugation with carboxylic acids or esters;^[@ref4]^ certain enamide substrates can also be reduced effectively.^[@ref5]^ Even for these relatively narrowly defined groups of substrates, successful CAH typically requires elevated temperature and high pressure of H~2~.

Recently, α-methyl-β-cyclopropyldihydrocinnamates were identified as potentially important pharmacophores. A comprehensive study by Christensen et al.^[@ref6]^ evaluated the CAH of tetrasubstituted cinnamate ester **1** using an extensive collection of catalyst systems. Rhodium catalysts examined in the study are reported to give low yields of **2** due to the lability of the vinyl cyclopropane moiety. However, ruthenium catalysts incorporating Josiphos or JoSPOphos ligands give **2** with high enantiomer ratios (er) as shown in [Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}. The reaction conditions employ relatively high pressure (500 psi H~2~), elevated temperature (80 °C), and an extended reaction time (20 h). Herein, we report the ability to reduce tri- and tetrasubstituted alkenes under exceptionally mild conditions. For example, 1% \[Rh(nbd)~2~BF~4~/(*R*)-**B2**\]) catalyzes the CAH of the tetrasubstituted alkene (*Z*)-**3** at ambient temperature to afford (2*R*,3*S*)-**4** (95%, \>25:1 dr, 95:5 er). H~2~ is presumably generated in stoichiometric amount in situ from pinBH and MeOH.^[@ref7]^
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The CAH conditions described above evolved from ongoing studies directed toward the preparation of functionalized chiral boronic esters via directed-catalytic asymmetric hydroboration (CAHB).^[@ref8]^ Chiral boronic esters are versatile intermediates^[@ref9]^ and especially useful for diversity-oriented synthesis.^[@ref10]^ Consequently, the development of catalysts for CAHB is receiving much attention.^[@ref11]^ We and others often find varying amounts of the reduced alkene accompany the desired borylated product under the conditions of rhodium- and other metal-catalyzed hydroborations.^[@ref12]^ For example, the formation of chiral tertiary boronic ester **6a** (77%, 94:6 er) via CAHB of trisubstituted alkene (*E*)-**5a** ([Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"})^[@ref13]^ is accompanied by the reduced product **7a** (15%, 60:40 er). To the best of our knowledge, the mechanism for formation of the reduced byproduct has never been completely determined. Protodeborylation^[@ref14]^ of an initially formed borylated product is a possibility. The more common assumption is that the reduced product is formed due to the presence of H~2~ resulting from adventitious moisture (or other proton source) affecting partial decomposition of the borane (e.g., pinBH).^[@ref15]^
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In support of the proposal that adventitious proton sources enable reduction, we added slightly more than a stoichiometric equivalent of a proton source (1.2 equiv MeOH) to the mixture of substrate (*E*)-**5a**, catalyst, and pinBH (1.5 equiv). The yield of reduced product **7a** increases to near quantitative under those conditions; however, enantiomer ratio (er) remains close to racemic. To improve the enantioselectivity, we screened variety of simple, chiral TADDOL- and BINOL-derived phosphite and phosphoramidite ligands^[@ref16]^ finding that (*R*)-**B2** gives (*R*)-**7a** with excellent yield and high enantioselectivity (98%, 99:1 er).^[@ref17]^ Similar results are obtained by omitting MeOH but running the reaction under an atmosphere of H~2~.

[Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"} illustrates the scope of oxime-directed CAH of trisubstituted and tetrasubstituted alkenes.^[@ref18]^ In each example shown, (\[Rh(nbd)~2~BF~4~\]/(*R*)-**B2**) is employed using the pinBH/MeOH protocol; in selected cases, results are also reported using the pinBH/H~2~ protocol or using (*S*)-**B2**. For example, (*E*)-**5b** (R = Me, R^*E*^ = Ph) undergoes CAH using either the pinBH/MeOH or pinBH/H~2~ protocol; (*R*)-**7b** is obtained in near quantitative yield and high enantioselectivity (99:1 and 97:3 er, respectively).^[@ref19]^ In contrast, we see no evidence for rhodium-catalyzed reduction of (*E*)-**5b** under H~2~ atmosphere up to 50 psi (12 h) without pinBH present.
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Other trisubstituted substrates bearing an aryl substituent in the 2-position (i.e., (*E*)-**5c**) or with simple alkyl substituents in both positions (i.e., **5d** and **5e**) similarly give reduced products in high yield (87--97%) and with high levels of enantioselectivity (94:6 er or greater). In the case of substrate **5f**, ligand **B3** gives an improved level of enantioselectivity (95:5 er compared to 92:8 using **B2**). For substrate **5g**, the er improves from 91:9 to 99:1 when starting with the (*Z*)-isomer. Substrate **5g** illustrates another important feature of the chemistry. Although **5g** possesses two trisubstituted alkene moieties, only the double bond proximal to the oxime moiety is reduced. Chiral substrate (5*S*)-**5h** demonstrates good catalyst-controlled reduction. Either (2*R*,5*S*)- or (2*S*,5*S*)-**7h** (95:5 dr) is formed at will by employing the (*R*)- or (*S*)-enantiomer of **B2**, respectively. However, the resident allylic stereocenter in the related chiral acetal (4*S*)-**5i** exerts modest influence leading to a matched (99:1 dr)/mismatched (85:15 dr) case of double stereodifferentiation.

Unactivated, all-alkyl tetrasubstituted alkenes are generally found to be very challenging substrates for CAH. Nevertheless, tetrasubstituted alkenes **8a** and **8b** correspondingly yield **9a** and **9b** with high enantioselectivity using the pinBH/MeOH setting a single stereocenter in the course of hydrogenation. Tetrasubstituted alkenes (*E*)-**8c** and (*Z*)-**8c** demonstrate that hydrogenation proceeds via stereospecific *syn*-addition. The (*E*)-isomer affords (2*R*,3*S*)-**9c** (95%, 92:8 er); the (*Z*)-isomer affords (2*R*,3*R*)-**9c** (92%, 96:4 er). Similar results are obtained for (*E*)- and (*Z*)-**8d**. Aryl substituents are tolerated as illustrated above in the reduction of (*Z*)-**3** to (2*R*,3*S*)-**4** (95%, 95:5 er) ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}). Using the pinBH/MeOH protocol, (*E*)-**8e** affords (2*R*,3*R*)-**9e** (90%, 93:7 er); (*Z*)-**8e** affords (2*R*,3*S*)-**9e** (88%, 97:3 er). The yield and er are improved for (*Z*)-**8e** using the pinBH/H~2~ protocol; (2*R*,3*S*)-**9e** is obtained in 95% yield (99:1 er). The pinBH/H~2~ protocol also improves the results obtained with the diaryl substrate **8f**. (*R*)-**9f** is obtained in a 75:25 er (82%) using pinBH/MeOH but in 95:5 er (95% yield) using the pinBH/H~2~ protocol.

To demonstrate the synthetic utility of this CAH of tetrasubstituted alkenes two simple natural products, (−)-enterodiol and (−)-lasiol, were prepared, albeit with a major surprise revealed en route to each ([Scheme [4](#sch4){ref-type="scheme"}](#sch4){ref-type="scheme"}). Two syntheses of (−)-enterodiol have been published. The Feringa route features the diastereoselective tandem conjugate addition to a chiral alkoxybutenolide,^[@ref20]^ and Sjöholm reported its preparation starting from hydroxymatairesinol.^[@ref21]^ In the present route, CAH of (*E*)-**10** using (*R*)-**B2** and the pinBH/MeOH protocol proceeds in good yield with high diastereo- and enantioselectivity (\>25:1 dr, 99:1 er). On the basis of correlations to known compounds for seven of the reduced products shown above, we expected the (*R*)-**B2** catalyst would give (2*R*,3*R*)-**11**; however, in the event, (2*S*,3*S*)-**11** was obtained. We can only speculate that the multiple potential ligating groups in **10** combine to reverse the sense of π-facial discrimination for this substrate. Although mechanistically intriguing, the unexpected enantioswitching^[@ref22]^ is of little consequence from a practical standpoint. Given the simplicity of the ligand used, (*S*)-**B2** is equally accessible and affords (2*R*,3*R*)-**11** (83%, 97:3 er). Cleavage of methyl and benzyl ethers and cleavage of the N--O bond to remove the oxime directing group affords (−)-enterodiol.
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Three published routes to (−)-lasiol involve asymmetric catalysis to set one of the two stereocenters: Kobayshi exploited the 1,4-addition to an unsaturated amide;^[@ref23]^ Feringa used enantioselective allylic alkylation followed by a diastereoselective conjugated addition;^[@ref24]^ and Burgess exploited catalyst-controlled CAH of a chiral trisubstituted alkene.^[@ref25]^ Our route is the first wherein the two chiral centers are generated in a single step. CAH of (*Z*)-**12** using the pinBH/MeOH protocol again proceeds with opposite to the expected sense of stereoinduction necessitating the use of (*R*)-**B2** to produce (2*S*,3*S*)-**13** (98%, 95:5 er) as required for the natural product. CAH is selective for the proximal tetrasubstituted alkene in the presence of a trisubstituted double bond. Cleavage of the N--O bond affords (−)-lasiol.

Phosphoramidite ligands have been extensively studied in rhodium-catalyzed CAH both from the synthetic^[@ref26]^ and mechanistic perspectives.^[@ref27]^[Scheme [5](#sch5){ref-type="scheme"}](#sch5){ref-type="scheme"} outlines a simple unified model, an "interrupted hydroboration" pathway,^[@ref28]^ to account for the apparent competition between CAH and CAHB^[@ref29]^ under the conditions described herein. Two-point binding of the substrate (**SM**) to Rh and oxidative addition of pinBH gains access to intermediate **I**. Insertion of the alkene into the Rh--H bond would generate a species such as intermediate **II**. Reductive elimination from **II** would afford the borylated product **(BP**) with regeneration of intermediate **I**. Alternately, σ-bond metathesis of rhodium-boryl complex **II** with H~2~^[@ref30]^ would generate the reduced product (**RP**) and, in the presence of additional alkene substrate, regenerate intermediate **II** to continue the cycle.

![Potential Competing Pathways for Borane-Promoted CAHB and CAH](ja-2017-02581z_0005){#sch5}

In summary, an unwanted side reaction leading to a reduction byproduct during CAHB is turned into an efficient method for oxime-directed, borane promoted CAH of challenging tri- and tetrasubstituted alkenes. To our knowledge, this report constitutes the first examples using an oxime to direct CAH as well as a new catalyst system for efficient CAH. The mild reduction conditions, short reaction times, and the need for only a slight excess above stoichiometric H~2~ contrast those used in state-of-the-art catalysts even for activated tetrasubstituted substrates. Stereospecific *syn*-hydrogenation is enabled via the combination of a simple 1:1 \[Rh(I)/chiral phosphoramidite\] catalyst system (e.g., \[Rh(nbd)~2~BF~4~/(*R*)-**B2**\]), pinBH and H~2~, the latter either generated in situ or as atmosphere above the reaction mixture. Borane is required for reduction. The method works well for aryl-substituted alkene substrates as well as for the more challenging case of all-alkyl tetrasubstituted alkenes. In substrates bearing an additional double bond, only the proximal alkene with respect to the oxime moiety is reduced; however, the sense of π-facial selectivity can apparently be influenced by remote donor substituents. A simple catalytic cycle in which CAHB is diverted to CAH via σ-bond metathesis of a rhodium--boryl intermediate with H~2~ can be drawn; however, the actual mechanism is likely to be more complicated. Further studies and extension of the method to other classes of substrates are in progress.
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